Mounjaro is available in several dose strengths, and gradual dose escalation is an important part of treatment with tirzepatide. Starting at a high dose or increasing the dose too quickly should not be viewed as a shortcut to faster weight loss.

Treatment begins at a low dose and is increased gradually according to the prescribed schedule, treatment response and tolerability.

What Mounjaro doses are available?

Mounjaro is available in strengths including 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. It is administered by subcutaneous injection once weekly.

What is the starting dose of Mounjaro?

According to official prescribing information for adults, treatment starts with 2.5 mg once weekly for four weeks. The dose is then generally increased to 5 mg once weekly.

The 2.5 mg dose is intended for treatment initiation. It allows the body time to adjust to tirzepatide and should not be considered a reason to accelerate dose escalation.

How is the Mounjaro dose increased?

After reaching 5 mg, additional increases may be made in 2.5 mg increments when needed, after at least four weeks on the current dose.

The sequence can therefore include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and eventually 15 mg. However, not every patient needs to reach the maximum dose.

Why are doses increased gradually?

Common tirzepatide side effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, constipation, indigestion and abdominal pain.

Gradual escalation gives the body time to adjust to treatment and can improve tolerability. Increasing the dose faster than recommended may increase problems rather than improve results.

Does a higher dose mean greater weight loss?

In the SURMOUNT-1 trial, average weight reduction after 72 weeks was approximately 15% with 5 mg, 19.5% with 10 mg and 20.9% with 15 mg.

However, these averages do not mean that the highest dose is appropriate for everyone. Some people may respond well at a lower dose, while others may experience side effects that limit dose escalation.

The objective is to use an appropriate dose based on individual response and medical assessment, rather than simply reaching 15 mg.

Should the dose be increased if weight loss slows?

A short period of stable weight does not automatically mean that the dose should be increased. Weight-loss rates naturally change over time, while diet, activity, sleep and other health factors can also affect progress.

If weight loss slows or stops for a prolonged period, the treatment plan should be reviewed with a healthcare professional.

What if side effects appear after a dose increase?

Gastrointestinal symptoms may appear or become more noticeable during dose escalation. Severe or persistent symptoms should be discussed with a healthcare professional.

Tirzepatide also has other warnings and precautions, so treatment decisions should not be based on the experiences or dosing schedules of other users.

Conclusion

Mounjaro treatment in adults generally begins at 2.5 mg once weekly and is increased gradually when appropriate. Available strengths extend up to 15 mg once weekly, but reaching the highest dose is not the goal for every patient.

Dose selection depends on treatment response, tolerability and individual medical circumstances. The dose should never be increased faster simply to accelerate weight loss.

Medical notice: This article is for educational purposes and does not provide an individualized dosing recommendation or replace medical advice.